Trending Stock News

Equitec Proprietary Markets Cut Foundation Medicine (Call) (FMI) Stake By $1.19 Million; Ameriprise Financial Increased Zendesk (ZEN) Position By $1.46 Million

Ameriprise Financial Inc increased Zendesk Inc (ZEN) stake by 125.75% reported in 2017Q2 SEC filing. Ameriprise Financial Inc acquired 53,901 shares as Zendesk Inc (ZEN)’s stock declined 10.76%. The Ameriprise Financial Inc holds 96,764 shares with $2.69M value, up from 42,863 last quarter. Zendesk Inc now has $3.33 billion valuation. The stock increased 0.54% or $0.175 during the last trading session, reaching $32.755. About 181,965 shares traded. Zendesk, Inc. (NYSE:ZEN) has risen 6.73% since December 6, 2016 and is uptrending. It has underperformed by 9.97% the S&P500.

Equitec Proprietary Markets Llc decreased Foundation Medicine Inc (Call) (FMI) stake by 35.79% reported in 2017Q2 SEC filing. Equitec Proprietary Markets Llc sold 30,600 shares as Foundation Medicine Inc (Call) (FMI)’s stock rose 52.87%. The Equitec Proprietary Markets Llc holds 54,900 shares with $2.18M value, down from 85,500 last quarter. Foundation Medicine Inc (Call) now has $2.11 billion valuation. The stock decreased 1.21% or $0.71 during the last trading session, reaching $58.19. About 125,813 shares traded. Foundation Medicine, Inc. (NASDAQ:FMI) has risen 124.70% since December 6, 2016 and is uptrending. It has outperformed by 108.00% the S&P500.

Among 9 analysts covering Foundation Medicine (NASDAQ:FMI), 1 have Buy rating, 0 Sell and 8 Hold. Therefore 11% are positive. Foundation Medicine had 12 analyst reports since July 30, 2015 according to SRatingsIntel. BTIG Research upgraded the stock to “Buy” rating in Monday, May 15 report. The firm has “Neutral” rating by UBS given on Wednesday, September 21. On Wednesday, November 4 the stock rating was downgraded by BTIG Research to “Neutral”. On Thursday, November 3 the stock rating was downgraded by Benchmark to “Hold”. The firm has “Market Perform” rating by JMP Securities given on Thursday, July 30. As per Wednesday, September 16, the company rating was downgraded by Wells Fargo. BTIG Research initiated Foundation Medicine, Inc. (NASDAQ:FMI) rating on Monday, September 14. BTIG Research has “Buy” rating and $30 target. On Tuesday, March 7 the stock rating was upgraded by Janney Capital to “Neutral”.

Investors sentiment increased to 1.79 in 2017 Q2. Its up 0.93, from 0.86 in 2017Q1. It is positive, as 8 investors sold FMI shares while 20 reduced holdings. 18 funds opened positions while 32 raised stakes. 9.72 million shares or 8.41% more from 8.97 million shares in 2017Q1 were reported. Sg Americas Secs Ltd Limited Liability Company holds 0% or 4,745 shares. Macquarie Gp Limited reported 0.01% stake. Ipswich Investment Management Incorporated holds 0.3% of its portfolio in Foundation Medicine, Inc. (NASDAQ:FMI) for 16,350 shares. Platinum Ltd owns 90,700 shares or 0.1% of their US portfolio. Winslow Evans & Crocker Inc holds 40 shares or 0% of its portfolio. Credit Suisse Ag has 0% invested in Foundation Medicine, Inc. (NASDAQ:FMI). Rhumbline Advisers reported 16,628 shares. 1,258 are held by Ameritas Prtn Incorporated. California State Teachers Retirement Sys invested in 25,421 shares or 0% of the stock. Fmr holds 0% or 84,571 shares in its portfolio. Amp Capital Investors Ltd stated it has 6,020 shares or 0% of all its holdings. Nationwide Fund holds 0% or 7,791 shares. Fincl Bank Of New York Mellon Corp holds 0% in Foundation Medicine, Inc. (NASDAQ:FMI) or 61,597 shares. Moreover, Baillie Gifford & has 0.01% invested in Foundation Medicine, Inc. (NASDAQ:FMI) for 248,300 shares. Us Bancshares De invested 0% of its portfolio in Foundation Medicine, Inc. (NASDAQ:FMI).

Analysts await Foundation Medicine, Inc. (NASDAQ:FMI) to report earnings on February, 28. They expect $-0.98 earnings per share, up 3.92% or $0.04 from last year’s $-1.02 per share. After $-0.90 actual earnings per share reported by Foundation Medicine, Inc. for the previous quarter, Wall Street now forecasts 8.89% negative EPS growth.

Equitec Proprietary Markets Llc increased Cabelas Inc (Put) (NYSE:CAB) stake by 155,700 shares to 161,200 valued at $9.58 million in 2017Q2. It also upped Mobileye N V Amstelveen (NYSE:MBLY) stake by 7,000 shares and now owns 12,000 shares. Esperion Therapeutics Inc Ne (Put) (NASDAQ:ESPR) was raised too.

Ameriprise Financial Inc decreased Northwest Pipe Co (NASDAQ:NWPX) stake by 98,360 shares to 235,638 valued at $3.83M in 2017Q2. It also reduced A stake by 48,894 shares and now owns 117,223 shares. Hff Inc (NYSE:HF) was reduced too.

Among 19 analysts covering Zendesk (NYSE:ZEN), 16 have Buy rating, 1 Sell and 2 Hold. Therefore 84% are positive. Zendesk had 44 analyst reports since August 5, 2015 according to SRatingsIntel. Canaccord Genuity maintained Zendesk, Inc. (NYSE:ZEN) rating on Tuesday, August 8. Canaccord Genuity has “Buy” rating and $3400 target. The rating was initiated by Summit Research with “Buy” on Monday, March 28. The stock of Zendesk, Inc. (NYSE:ZEN) has “Buy” rating given on Thursday, November 2 by Wells Fargo. The stock of Zendesk, Inc. (NYSE:ZEN) has “Buy” rating given on Thursday, August 24 by KeyBanc Capital Markets. The company was initiated on Tuesday, July 19 by Stifel Nicolaus. Evercore initiated Zendesk, Inc. (NYSE:ZEN) on Friday, September 8 with “Outperform” rating. The stock has “Outperform” rating by William Blair on Thursday, September 10. The stock of Zendesk, Inc. (NYSE:ZEN) earned “Hold” rating by Stifel Nicolaus on Friday, July 21. The rating was maintained by Rosenblatt on Wednesday, November 4 with “Buy”. Zacks downgraded the shares of ZEN in report on Wednesday, August 5 to “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *